Clinical Program Development, Renown Institute for Cancer, Renown Regional Medical Center, Reno, NV 89523, USA.
Cancer J. 2010 Nov-Dec;16(6):600-5. doi: 10.1097/PPO.0b013e3181feeba1.
Cancer leaders assess the impact on the cancer patient of the historic passage of Patient Protection and Affordable Care Act (HR 3590) (PPACA). The Association of Cancer Executives, a national organization for leadership development of oncology executives and improvements in patient care delivery, and the Association of Community Cancer Centers, a leading education and advocacy organization for the cancer team, weigh in on the impact of PPACA. Oncology leaders assess the impact of PPACA on cancer patients and families, cancer programs in the United States, and provider relations. The provisions of PPACA most impacting cancer patients are reviewed, including reimbursement changes, expansion of prevention and screening services, the development of accountable care organizations, physician relations, and the implementation of integrated electronic health records. Cancer executives prepare their programs for PPACA by changing the care delivery model to ensure the economic survival of private practices and hospital-based programs.
癌症领域的领导者评估了《患者保护与平价医疗法案》（HR 3590）（PPACA）历史性通过对癌症患者的影响。癌症执行协会是一家专注于肿瘤学高管领导力发展和改善患者护理服务的全国性组织，社区癌症中心协会是癌症团队的主要教育和倡导组织，它们对 PPACA 的影响发表了看法。肿瘤学领导者评估了 PPACA 对癌症患者和家庭、美国癌症项目以及医疗服务提供者关系的影响。审查了对癌症患者影响最大的 PPACA 条款，包括报销变更、扩大预防和筛查服务、建立问责制医疗组织、医患关系以及实施综合电子健康记录。癌症高管通过改变护理提供模式为 PPACA 做准备，以确保私人诊所和医院项目的经济生存能力。
